<- Go Home

Synergy Innovation Co., Ltd.

Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation – universal transport solutions (SI-UTS); and invests and develops in various fields comprising microorganism, bacteria, and virus. The company also provides pharmaceutical formulations; and develops non-vascular stents. Synergy Innovation Co., Ltd. was founded in 1998 and is headquartered in Seongnam-Si, South Korea.

Market Cap

KRW 229.1B

Volume

1.3M

Cash and Equivalents

KRW 71.5B

EBITDA

KRW 20.3B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

KRW 37.9B

Profit Margin

41.79%

52 Week High

KRW 3.6K

52 Week Low

KRW 2.1K

Dividend

N/A

Price / Book Value

1.27

Price / Earnings

22.16

Price / Tangible Book Value

1.44

Enterprise Value

KRW 216.0B

Enterprise Value / EBITDA

7.22

Operating Income

KRW 16.1B

Return on Equity

7.93%

Return on Assets

3.36

Cash and Short Term Investments

KRW 106.5B

Debt

KRW 41.1B

Equity

KRW 235.1B

Revenue

KRW 90.6B

Unlevered FCF

KRW 12.6B

Sector

Health Care Equipment and Supplies

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches